Fold Holdings, Inc. (FLD) is a forward-thinking biotechnology company that focuses on developing novel therapies for severe genetic and rare diseases, leveraging its cutting-edge research capabilities and proprietary technologies. With a diverse product pipeline enriched by strategic partnerships, Fold is strategically positioned to harness significant market opportunities and drive innovation in the healthcare landscape. The company’s unwavering commitment to scientific advancement and patient-centric solutions positions it as a compelling investment opportunity within the dynamic and…